Literature DB >> 20940074

Universal access to malaria medicines: innovation in financing and delivery.

Olusoji Adeyi1, Rifat Atun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20940074     DOI： 10.1016/S0140-6736(10)61189-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

Review 1.  Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum.

Authors:  Connor O'Brien; Philipp P Henrich; Neha Passi; David A Fidock
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

2.  Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda.

Authors:  Jessica L Cohen; Elif Yavuz; Alexandra Morris; Jean Arkedis; Oliver Sabot
Journal:  Malar J       Date:  2012-03-23       Impact factor: 2.979

3.  Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania.

Authors:  Allen Lewis Malisa; Deodatus Kiriba
Journal:  BMC Res Notes       Date:  2012-03-28

4.  Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi.

Authors:  John H Amuasi; Graciela Diap; Samuel Blay-Nguah; Isaac Boakye; Patrick E Karikari; Baza Dismas; Jeanne Karenzo; Lievin Nsabiyumva; Karly S Louie; Jean-René Kiechel
Journal:  Malar J       Date:  2011-02-10       Impact factor: 2.979

5.  Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.

Authors:  Shunmay Yeung; Edith Patouillard; Henrietta Allen; Duong Socheat
Journal:  Malar J       Date:  2011-08-18       Impact factor: 2.979

6.  Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective.

Authors:  Allen Malisa; Richard Pearce; Benezeth Mutayoba; Salim Abdullah; Hassan Mshinda; Patrick Kachur; Peter Bloland; Cally Roper
Journal:  Malar Res Treat       Date:  2011-06-20

7.  Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone.

Authors:  John H Amuasi; Graciela Diap; Samuel Blay Nguah; Patrick Karikari; Isaac Boakye; Amara Jambai; Wani Kumba Lahai; Karly S Louie; Jean-Rene Kiechel
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

8.  Methods for implementing a medicine outlet survey: lessons from the anti-malarial market.

Authors:  Kathryn A O'Connell; Stephen Poyer; Tsione Solomon; Erik Munroe; Edith Patouillard; Julius Njogu; Illah Evance; Kara Hanson; Tanya Shewchuk; Catherine Goodman
Journal:  Malar J       Date:  2013-02-05       Impact factor: 2.979

9.  Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.

Authors:  Sarah V Kedenge; Beth P Kangwana; Evelyn W Waweru; Andrew J Nyandigisi; Jayesh Pandit; Simon J Brooker; Robert W Snow; Catherine A Goodman
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.

Authors:  Ambrose O Talisuna; Penny Grewal Daumerie; Andrew Balyeku; Timothy Egan; Bram Piot; Renia Coghlan; Maud Lugand; Godfrey Bwire; John Bosco Rwakimari; Richard Ndyomugyenyi; Fred Kato; Maria Byangire; Paul Kagwa; Fred Sebisubi; David Nahamya; Angela Bonabana; Susan Mpanga-Mukasa; Peter Buyungo; Julius Lukwago; Allan Batte; Grace Nakanwagi; James Tibenderana; Kinny Nayer; Kishore Reddy; Nilesh Dokwal; Sylvester Rugumambaju; Saul Kidde; Jaya Banerji; George Jagoe
Journal:  Malar J       Date:  2012-10-29       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.